AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVEX THERAPEUTICS LTD

0.125

0.000

Volume:5.33K

Turnover:666.00

Market Cap:9.39M

PE:-11.28

High:0.125

Open:0.125

Low:0.125

Close:0.125

52wk High:0.180

52wk Low:0.059

Shares:75.15M

Float Shares:46.42M

Volume Ratio:0.75

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.011

EPS(LYR):-0.006

ROE:-16.83%

ROA:-12.75%

PB:2.07

PE(LYR):-19.84

Loading ...

Overview Company News Filings

Company Profile

Company Name:

INVEX THERAPEUTICS LTD

Exchange:

ASX

Establishment Date:

2019

Employees:

- -

Office Location:

38 Rowland Street,Level 2,Subiaco,Western Australia,Australia

Website:

http://www.invextherapeutics.com

Zip Code:

6008

Phone:

Fax:

- -

Introduction:

Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury. The company was incorporated in 2019 and is based in Subiaco, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IXC.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IXC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IXC.AU\",,,,,undefined,":{"symbol":"IXC.AU","market":"AU","secType":"STK","nameCN":"INVEX THERAPEUTICS LTD","latestPrice":0.125,"timestamp":1771806349219,"preClose":0.125,"halted":0,"volume":5327,"delay":0,"changeRate":0,"nameEN":"INVEX THERAPEUTICS LTD","floatShares":46419706,"shares":75153848,"eps":-0.011082,"marketStatus":"Trading","change":0,"latestTime":"02-23 11:28:35 AEDT","open":0.125,"high":0.125,"low":0.125,"amount":666,"amplitude":0,"askPrice":0.13,"askSize":28707,"bidPrice":0.11,"bidSize":33858,"shortable":3,"etf":0,"ttmEps":-0.011082,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771822800000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.125,"openAndCloseTimeList":[[1771801200000,1771822800000]],"volumeRatio":0.748736,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IXC.AU\",,,,,undefined,":{"symbol":"IXC.AU","floatShares":46419706,"roa":"-12.75%","roe":"-16.83%","lyrEps":-0.0063,"volumeRatio":0.748736,"shares":75153848,"dividePrice":0,"high":0.125,"amplitude":0,"preClose":0.125,"low":0.125,"week52Low":0.059,"pbRate":"2.07","psRate":"41.01","week52High":0.18,"institutionHeld":0,"latestPrice":0.125,"committee":0.08233,"eps":-0.011082,"divideRate":0,"volume":5327,"delay":0,"ttmEps":-0.011082,"open":0.125,"prevYearClose":0.12,"prevWeekClose":0.125,"prevMonthClose":0.13,"prevQuarterClose":0.12,"fiveDayClose":0.12,"twentyDayClose":0.115,"sixtyDayClose":0.115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":3.105},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IXC.AU\",params:#limit:5,,,undefined,":[{"date":"2023-12-08","symbol":"IXC.AU","amount":0.1863,"announcedDate":"2023-11-30","type":"dividend","market":"AU","newRecordDate":"2023-12-11","defaultRemindTime":1701990000000,"name":"Invex Therapeutics","recordDate":"2023-12-18","payableDate":"2023-12-11","currency":"AUD","dateTimestamp":1701954000000,"payDate":"2023-12-18"},{"date":"2023-04-20","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1681948800000,"name":null,"time":"","dateTimestamp":1681912800000,"actualEps":null},{"date":"2023-01-25","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1674601200000,"name":null,"time":"","dateTimestamp":1674565200000,"actualEps":null},{"date":"2022-10-27","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1666825200000,"name":null,"time":"","dateTimestamp":1666789200000,"actualEps":null},{"date":"2022-07-06","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1657065600000,"name":null,"time":"","dateTimestamp":1657029600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IXC.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-12-08","recordDate":"2023-12-11","paymentDate":"2023-12-18","value":0.1863,"currency":"AUD"}],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":614309842,"yearFounded":2019,"address":"38 Rowland Street,Level 2,Subiaco,Western Australia,Australia","zipCode":"6008","officePhone":"61 8 6382 0137"},"stockCompanyDetail":{"websiteUrl":"http://www.invextherapeutics.com","stockEarnings":[{"period":"1week","weight":0.1364},{"period":"1month","weight":0.0417},{"period":"3month","weight":0.0417},{"period":"6month","weight":0.2887},{"period":"1year","weight":0.6667},{"period":"ytd","weight":0.0417}],"compareEarnings":[{"period":"1week","weight":0.0173},{"period":"1month","weight":0.0113},{"period":"3month","weight":0.0666},{"period":"6month","weight":0.055},{"period":"1year","weight":0.2181},{"period":"ytd","weight":0.0215}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury. The company was incorporated in 2019 and is based in Subiaco, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.042193},{"month":2,"riseRate":0.5,"avgChangeRate":-0.047862},{"month":3,"riseRate":0.666667,"avgChangeRate":0.147696},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.015989},{"month":5,"riseRate":0,"avgChangeRate":-0.16993},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.029146},{"month":7,"riseRate":0.714286,"avgChangeRate":0.071585},{"month":8,"riseRate":0.714286,"avgChangeRate":0.084367},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.074966},{"month":10,"riseRate":0.428571,"avgChangeRate":0.041219},{"month":11,"riseRate":0.571429,"avgChangeRate":0.067784},{"month":12,"riseRate":0.857143,"avgChangeRate":0.057464}],"exchange":"ASX","name":"INVEX THERAPEUTICS LTD","nameEN":"INVEX THERAPEUTICS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IXC.AU\",market:\"AU\",,,undefined,":null}}